nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—Isoetarine—asthma	0.299	0.569	CrCtD
Methyldopa—Isoprenaline—asthma	0.227	0.431	CrCtD
Methyldopa—Isoetarine—Orciprenaline—asthma	0.0226	0.0606	CrCrCtD
Methyldopa—Dopamine—Isoetarine—asthma	0.0176	0.0472	CrCrCtD
Methyldopa—Norepinephrine—Isoetarine—asthma	0.0176	0.0472	CrCrCtD
Methyldopa—Droxidopa—Isoetarine—asthma	0.0176	0.0472	CrCrCtD
Methyldopa—Epinephrine—Pirbuterol—asthma	0.017	0.0455	CrCrCtD
Methyldopa—Levonordefrin—Isoetarine—asthma	0.0165	0.0443	CrCrCtD
Methyldopa—Epinephrine—Orciprenaline—asthma	0.016	0.0428	CrCrCtD
Methyldopa—Carbidopa—Isoprenaline—asthma	0.0155	0.0414	CrCrCtD
Methyldopa—Isoetarine—Isoprenaline—asthma	0.0143	0.0384	CrCrCtD
Methyldopa—Epinephrine—Terbutaline—asthma	0.0139	0.0371	CrCrCtD
Methyldopa—Norepinephrine—Isoprenaline—asthma	0.0134	0.0358	CrCrCtD
Methyldopa—Dopamine—Isoprenaline—asthma	0.0134	0.0358	CrCrCtD
Methyldopa—Droxidopa—Isoprenaline—asthma	0.0134	0.0358	CrCrCtD
Methyldopa—Epinephrine—Isoetarine—asthma	0.0133	0.0357	CrCrCtD
Methyldopa—Isoprenaline—Orciprenaline—asthma	0.013	0.0348	CrCrCtD
Methyldopa—Isoetarine—Salbutamol—asthma	0.013	0.0348	CrCrCtD
Methyldopa—Levonordefrin—Isoprenaline—asthma	0.0125	0.0336	CrCrCtD
Methyldopa—Norepinephrine—Salbutamol—asthma	0.0121	0.0325	CrCrCtD
Methyldopa—L-DOPA—Isoetarine—asthma	0.0117	0.0314	CrCrCtD
Methyldopa—Levonordefrin—Salbutamol—asthma	0.0114	0.0305	CrCrCtD
Methyldopa—Isoprenaline—Terbutaline—asthma	0.0113	0.0302	CrCrCtD
Methyldopa—Isoprenaline—Isoetarine—asthma	0.0109	0.0291	CrCrCtD
Methyldopa—Epinephrine—Isoprenaline—asthma	0.0101	0.0271	CrCrCtD
Methyldopa—Isoprenaline—Formoterol—asthma	0.00986	0.0264	CrCrCtD
Methyldopa—Isoprenaline—Arformoterol—asthma	0.00986	0.0264	CrCrCtD
Methyldopa—Epinephrine—Salbutamol—asthma	0.00918	0.0246	CrCrCtD
Methyldopa—L-DOPA—Isoprenaline—asthma	0.00888	0.0238	CrCrCtD
Methyldopa—Isoprenaline—Salbutamol—asthma	0.00747	0.02	CrCrCtD
Methyldopa—DDC—respiratory system—asthma	0.000739	0.13	CbGeAlD
Methyldopa—COMT—respiratory system—asthma	0.000488	0.0858	CbGeAlD
Methyldopa—SLC15A1—epithelium—asthma	0.000459	0.0806	CbGeAlD
Methyldopa—DDC—adrenal gland—asthma	0.000447	0.0786	CbGeAlD
Methyldopa—COMT—adrenal cortex—asthma	0.00041	0.072	CbGeAlD
Methyldopa—Aminosalicylic Acid—ALOX5—asthma	0.000408	0.252	CrCbGaD
Methyldopa—COMT—bronchus—asthma	0.000402	0.0706	CbGeAlD
Methyldopa—COMT—smooth muscle tissue—asthma	0.000393	0.0691	CbGeAlD
Methyldopa—DDC—lung—asthma	0.000392	0.0689	CbGeAlD
Methyldopa—COMT—cardiovascular system—asthma	0.000374	0.0657	CbGeAlD
Methyldopa—COMT—trachea—asthma	0.000361	0.0634	CbGeAlD
Methyldopa—Mesalazine—ALOX5—asthma	0.00032	0.198	CrCbGaD
Methyldopa—COMT—adrenal gland—asthma	0.000296	0.052	CbGeAlD
Methyldopa—COMT—lung—asthma	0.000259	0.0456	CbGeAlD
Methyldopa—Isoetarine—ADRB2—asthma	0.000238	0.147	CrCbGaD
Methyldopa—ADRA2A—bronchus—asthma	0.000205	0.036	CbGeAlD
Methyldopa—ADRA2A—trachea—asthma	0.000184	0.0323	CbGeAlD
Methyldopa—ADRA2A—adrenal gland—asthma	0.000151	0.0265	CbGeAlD
Methyldopa—ADRA2A—lung—asthma	0.000132	0.0232	CbGeAlD
Methyldopa—Droxidopa—ADRB2—asthma	0.000109	0.0672	CrCbGaD
Methyldopa—Isoprenaline—ADRB2—asthma	9.9e-05	0.0611	CrCbGaD
Methyldopa—Aminosalicylic Acid—PTGS2—asthma	9.87e-05	0.0609	CrCbGaD
Methyldopa—Epinephrine—TNF—asthma	9.38e-05	0.0579	CrCbGaD
Methyldopa—Norepinephrine—ADRB2—asthma	9.17e-05	0.0566	CrCbGaD
Methyldopa—Epinephrine—ADRB2—asthma	8.32e-05	0.0513	CrCbGaD
Methyldopa—Mesalazine—PTGS2—asthma	7.74e-05	0.0478	CrCbGaD
Methyldopa—Headache—Salmeterol—asthma	5.79e-05	0.000874	CcSEcCtD
Methyldopa—Weight increased—Prednisolone—asthma	5.79e-05	0.000874	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Formoterol—asthma	5.77e-05	0.00087	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Arformoterol—asthma	5.77e-05	0.00087	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Salbutamol—asthma	5.75e-05	0.000867	CcSEcCtD
Methyldopa—Pancreatitis—Triamcinolone—asthma	5.74e-05	0.000866	CcSEcCtD
Methyldopa—Pancreatitis—Methylprednisolone—asthma	5.73e-05	0.000864	CcSEcCtD
Methyldopa—Constipation—Arformoterol—asthma	5.72e-05	0.000862	CcSEcCtD
Methyldopa—Constipation—Formoterol—asthma	5.72e-05	0.000862	CcSEcCtD
Methyldopa—Nausea—Ipratropium bromide—asthma	5.69e-05	0.000858	CcSEcCtD
Methyldopa—Diarrhoea—Loratadine—asthma	5.68e-05	0.000856	CcSEcCtD
Methyldopa—Paraesthesia—Salbutamol—asthma	5.67e-05	0.000855	CcSEcCtD
Methyldopa—Weight increased—Hydrocortisone—asthma	5.66e-05	0.000853	CcSEcCtD
Methyldopa—Hypersensitivity—Flunisolide—asthma	5.66e-05	0.000853	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Montelukast—asthma	5.65e-05	0.000853	CcSEcCtD
Methyldopa—Body temperature increased—Mometasone—asthma	5.63e-05	0.000849	CcSEcCtD
Methyldopa—Vomiting—Aminophylline—asthma	5.58e-05	0.000842	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Budesonide—asthma	5.57e-05	0.00084	CcSEcCtD
Methyldopa—Infestation NOS—Hydrocortisone—asthma	5.54e-05	0.000836	CcSEcCtD
Methyldopa—Infestation—Hydrocortisone—asthma	5.54e-05	0.000836	CcSEcCtD
Methyldopa—Rash—Aminophylline—asthma	5.54e-05	0.000835	CcSEcCtD
Methyldopa—Dermatitis—Aminophylline—asthma	5.53e-05	0.000835	CcSEcCtD
Methyldopa—Asthenia—Flunisolide—asthma	5.51e-05	0.000831	CcSEcCtD
Methyldopa—Nausea—Fluticasone Propionate—asthma	5.51e-05	0.000831	CcSEcCtD
Methyldopa—Headache—Aminophylline—asthma	5.5e-05	0.00083	CcSEcCtD
Methyldopa—Nausea—Salmeterol—asthma	5.49e-05	0.000829	CcSEcCtD
Methyldopa—Paraesthesia—Budesonide—asthma	5.49e-05	0.000828	CcSEcCtD
Methyldopa—Dizziness—Loratadine—asthma	5.49e-05	0.000828	CcSEcCtD
Methyldopa—Dizziness—Tiotropium—asthma	5.48e-05	0.000826	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Salbutamol—asthma	5.45e-05	0.000822	CcSEcCtD
Methyldopa—Constipation—Salbutamol—asthma	5.4e-05	0.000814	CcSEcCtD
Methyldopa—Weight increased—Triamcinolone—asthma	5.33e-05	0.000804	CcSEcCtD
Methyldopa—Weight increased—Methylprednisolone—asthma	5.32e-05	0.000802	CcSEcCtD
Methyldopa—Body temperature increased—Formoterol—asthma	5.28e-05	0.000797	CcSEcCtD
Methyldopa—Body temperature increased—Arformoterol—asthma	5.28e-05	0.000797	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Budesonide—asthma	5.28e-05	0.000796	CcSEcCtD
Methyldopa—Vomiting—Loratadine—asthma	5.27e-05	0.000796	CcSEcCtD
Methyldopa—Vomiting—Tiotropium—asthma	5.27e-05	0.000794	CcSEcCtD
Methyldopa—Diarrhoea—Flunisolide—asthma	5.25e-05	0.000792	CcSEcCtD
Methyldopa—Rash—Loratadine—asthma	5.23e-05	0.000789	CcSEcCtD
Methyldopa—Constipation—Budesonide—asthma	5.23e-05	0.000789	CcSEcCtD
Methyldopa—Psychotic disorder—Prednisone—asthma	5.23e-05	0.000788	CcSEcCtD
Methyldopa—Dermatitis—Loratadine—asthma	5.23e-05	0.000788	CcSEcCtD
Methyldopa—Rash—Tiotropium—asthma	5.22e-05	0.000788	CcSEcCtD
Methyldopa—Dermatitis—Tiotropium—asthma	5.22e-05	0.000787	CcSEcCtD
Methyldopa—Nausea—Aminophylline—asthma	5.22e-05	0.000787	CcSEcCtD
Methyldopa—Infestation NOS—Methylprednisolone—asthma	5.21e-05	0.000786	CcSEcCtD
Methyldopa—Infestation—Methylprednisolone—asthma	5.21e-05	0.000786	CcSEcCtD
Methyldopa—Headache—Loratadine—asthma	5.2e-05	0.000784	CcSEcCtD
Methyldopa—Headache—Tiotropium—asthma	5.19e-05	0.000783	CcSEcCtD
Methyldopa—Bradycardia—Prednisolone—asthma	5.19e-05	0.000782	CcSEcCtD
Methyldopa—Body temperature increased—Montelukast—asthma	5.17e-05	0.000781	CcSEcCtD
Methyldopa—Asthenia—Mometasone—asthma	5.11e-05	0.000771	CcSEcCtD
Methyldopa—Dizziness—Flunisolide—asthma	5.08e-05	0.000766	CcSEcCtD
Methyldopa—Bradycardia—Hydrocortisone—asthma	5.07e-05	0.000764	CcSEcCtD
Methyldopa—Body temperature increased—Salbutamol—asthma	4.99e-05	0.000753	CcSEcCtD
Methyldopa—Nausea—Loratadine—asthma	4.93e-05	0.000743	CcSEcCtD
Methyldopa—Hypersensitivity—Arformoterol—asthma	4.92e-05	0.000743	CcSEcCtD
Methyldopa—Hypersensitivity—Formoterol—asthma	4.92e-05	0.000743	CcSEcCtD
Methyldopa—Nausea—Tiotropium—asthma	4.92e-05	0.000742	CcSEcCtD
Methyldopa—Connective tissue disorder—Hydrocortisone—asthma	4.89e-05	0.000738	CcSEcCtD
Methyldopa—Vomiting—Flunisolide—asthma	4.88e-05	0.000736	CcSEcCtD
Methyldopa—Diarrhoea—Mometasone—asthma	4.87e-05	0.000735	CcSEcCtD
Methyldopa—Rash—Flunisolide—asthma	4.84e-05	0.00073	CcSEcCtD
Methyldopa—Dermatitis—Flunisolide—asthma	4.84e-05	0.000729	CcSEcCtD
Methyldopa—Weight increased—Dexamethasone—asthma	4.83e-05	0.000729	CcSEcCtD
Methyldopa—Weight increased—Betamethasone—asthma	4.83e-05	0.000729	CcSEcCtD
Methyldopa—Body temperature increased—Budesonide—asthma	4.83e-05	0.000729	CcSEcCtD
Methyldopa—Hypersensitivity—Montelukast—asthma	4.82e-05	0.000728	CcSEcCtD
Methyldopa—Headache—Flunisolide—asthma	4.81e-05	0.000725	CcSEcCtD
Methyldopa—Asthenia—Formoterol—asthma	4.8e-05	0.000723	CcSEcCtD
Methyldopa—Asthenia—Arformoterol—asthma	4.8e-05	0.000723	CcSEcCtD
Methyldopa—Bradycardia—Triamcinolone—asthma	4.77e-05	0.00072	CcSEcCtD
Methyldopa—Bradycardia—Methylprednisolone—asthma	4.76e-05	0.000718	CcSEcCtD
Methyldopa—Asthenia—Montelukast—asthma	4.7e-05	0.000709	CcSEcCtD
Methyldopa—Abdominal distension—Prednisone—asthma	4.66e-05	0.000702	CcSEcCtD
Methyldopa—Hypersensitivity—Salbutamol—asthma	4.65e-05	0.000701	CcSEcCtD
Methyldopa—Connective tissue disorder—Methylprednisolone—asthma	4.59e-05	0.000693	CcSEcCtD
Methyldopa—Diarrhoea—Formoterol—asthma	4.57e-05	0.00069	CcSEcCtD
Methyldopa—Diarrhoea—Arformoterol—asthma	4.57e-05	0.00069	CcSEcCtD
Methyldopa—Nausea—Flunisolide—asthma	4.56e-05	0.000688	CcSEcCtD
Methyldopa—Pancreatitis—Prednisone—asthma	4.53e-05	0.000684	CcSEcCtD
Methyldopa—Asthenia—Salbutamol—asthma	4.53e-05	0.000683	CcSEcCtD
Methyldopa—Vomiting—Mometasone—asthma	4.53e-05	0.000683	CcSEcCtD
Methyldopa—Hypersensitivity—Budesonide—asthma	4.5e-05	0.000679	CcSEcCtD
Methyldopa—Rash—Mometasone—asthma	4.49e-05	0.000677	CcSEcCtD
Methyldopa—Dermatitis—Mometasone—asthma	4.49e-05	0.000677	CcSEcCtD
Methyldopa—Diarrhoea—Montelukast—asthma	4.48e-05	0.000676	CcSEcCtD
Methyldopa—Headache—Mometasone—asthma	4.46e-05	0.000673	CcSEcCtD
Methyldopa—Dizziness—Formoterol—asthma	4.42e-05	0.000667	CcSEcCtD
Methyldopa—Dizziness—Arformoterol—asthma	4.42e-05	0.000667	CcSEcCtD
Methyldopa—Asthenia—Budesonide—asthma	4.39e-05	0.000662	CcSEcCtD
Methyldopa—Mental disorder—Hydrocortisone—asthma	4.36e-05	0.000658	CcSEcCtD
Methyldopa—Cardiac disorder—Methylprednisolone—asthma	4.34e-05	0.000654	CcSEcCtD
Methyldopa—Dizziness—Montelukast—asthma	4.33e-05	0.000653	CcSEcCtD
Methyldopa—Bradycardia—Betamethasone—asthma	4.33e-05	0.000653	CcSEcCtD
Methyldopa—Bradycardia—Dexamethasone—asthma	4.33e-05	0.000653	CcSEcCtD
Methyldopa—Diarrhoea—Salbutamol—asthma	4.32e-05	0.000651	CcSEcCtD
Methyldopa—Erectile dysfunction—Prednisone—asthma	4.26e-05	0.000643	CcSEcCtD
Methyldopa—Vomiting—Formoterol—asthma	4.25e-05	0.000641	CcSEcCtD
Methyldopa—Vomiting—Arformoterol—asthma	4.25e-05	0.000641	CcSEcCtD
Methyldopa—Angiopathy—Methylprednisolone—asthma	4.24e-05	0.00064	CcSEcCtD
Methyldopa—Nausea—Mometasone—asthma	4.23e-05	0.000638	CcSEcCtD
Methyldopa—Rash—Arformoterol—asthma	4.21e-05	0.000636	CcSEcCtD
Methyldopa—Rash—Formoterol—asthma	4.21e-05	0.000636	CcSEcCtD
Methyldopa—Mediastinal disorder—Methylprednisolone—asthma	4.21e-05	0.000636	CcSEcCtD
Methyldopa—Dermatitis—Formoterol—asthma	4.21e-05	0.000635	CcSEcCtD
Methyldopa—Dermatitis—Arformoterol—asthma	4.21e-05	0.000635	CcSEcCtD
Methyldopa—Weight increased—Prednisone—asthma	4.21e-05	0.000635	CcSEcCtD
Methyldopa—Headache—Arformoterol—asthma	4.19e-05	0.000632	CcSEcCtD
Methyldopa—Headache—Formoterol—asthma	4.19e-05	0.000632	CcSEcCtD
Methyldopa—Diarrhoea—Budesonide—asthma	4.18e-05	0.000631	CcSEcCtD
Methyldopa—Dizziness—Salbutamol—asthma	4.17e-05	0.00063	CcSEcCtD
Methyldopa—Vomiting—Montelukast—asthma	4.16e-05	0.000628	CcSEcCtD
Methyldopa—Rash—Montelukast—asthma	4.13e-05	0.000623	CcSEcCtD
Methyldopa—Dermatitis—Montelukast—asthma	4.12e-05	0.000622	CcSEcCtD
Methyldopa—Headache—Montelukast—asthma	4.1e-05	0.000619	CcSEcCtD
Methyldopa—Mental disorder—Methylprednisolone—asthma	4.1e-05	0.000618	CcSEcCtD
Methyldopa—Dizziness—Budesonide—asthma	4.04e-05	0.00061	CcSEcCtD
Methyldopa—Vomiting—Salbutamol—asthma	4.01e-05	0.000605	CcSEcCtD
Methyldopa—Rash—Salbutamol—asthma	3.98e-05	0.0006	CcSEcCtD
Methyldopa—Dermatitis—Salbutamol—asthma	3.98e-05	0.0006	CcSEcCtD
Methyldopa—Nausea—Arformoterol—asthma	3.97e-05	0.000599	CcSEcCtD
Methyldopa—Nausea—Formoterol—asthma	3.97e-05	0.000599	CcSEcCtD
Methyldopa—Headache—Salbutamol—asthma	3.95e-05	0.000596	CcSEcCtD
Methyldopa—Nausea—Montelukast—asthma	3.89e-05	0.000587	CcSEcCtD
Methyldopa—Vomiting—Budesonide—asthma	3.89e-05	0.000586	CcSEcCtD
Methyldopa—Angiopathy—Dexamethasone—asthma	3.86e-05	0.000582	CcSEcCtD
Methyldopa—Angiopathy—Betamethasone—asthma	3.86e-05	0.000582	CcSEcCtD
Methyldopa—Rash—Budesonide—asthma	3.85e-05	0.000581	CcSEcCtD
Methyldopa—Dermatitis—Budesonide—asthma	3.85e-05	0.000581	CcSEcCtD
Methyldopa—Headache—Budesonide—asthma	3.83e-05	0.000578	CcSEcCtD
Methyldopa—Bradycardia—Prednisone—asthma	3.77e-05	0.000569	CcSEcCtD
Methyldopa—Nausea—Salbutamol—asthma	3.75e-05	0.000565	CcSEcCtD
Methyldopa—Myalgia—Hydrocortisone—asthma	3.69e-05	0.000556	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	3.66e-05	0.000552	CcSEcCtD
Methyldopa—Connective tissue disorder—Prednisone—asthma	3.64e-05	0.000549	CcSEcCtD
Methyldopa—Nausea—Budesonide—asthma	3.63e-05	0.000548	CcSEcCtD
Methyldopa—Oedema—Prednisolone—asthma	3.62e-05	0.000546	CcSEcCtD
Methyldopa—Oedema—Hydrocortisone—asthma	3.53e-05	0.000533	CcSEcCtD
Methyldopa—Infection—Hydrocortisone—asthma	3.51e-05	0.00053	CcSEcCtD
Methyldopa—Myalgia—Triamcinolone—asthma	3.47e-05	0.000524	CcSEcCtD
Methyldopa—Nervous system disorder—Hydrocortisone—asthma	3.47e-05	0.000523	CcSEcCtD
Methyldopa—Arthralgia—Methylprednisolone—asthma	3.46e-05	0.000523	CcSEcCtD
Methyldopa—Myalgia—Methylprednisolone—asthma	3.46e-05	0.000523	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	3.44e-05	0.000519	CcSEcCtD
Methyldopa—Skin disorder—Hydrocortisone—asthma	3.43e-05	0.000518	CcSEcCtD
Methyldopa—Angiopathy—Prednisone—asthma	3.36e-05	0.000507	CcSEcCtD
Methyldopa—Oedema—Triamcinolone—asthma	3.33e-05	0.000502	CcSEcCtD
Methyldopa—Infection—Triamcinolone—asthma	3.31e-05	0.000499	CcSEcCtD
Methyldopa—Infection—Methylprednisolone—asthma	3.3e-05	0.000498	CcSEcCtD
Methyldopa—Nervous system disorder—Methylprednisolone—asthma	3.26e-05	0.000491	CcSEcCtD
Methyldopa—Paraesthesia—Prednisolone—asthma	3.25e-05	0.00049	CcSEcCtD
Methyldopa—Mental disorder—Prednisone—asthma	3.24e-05	0.000489	CcSEcCtD
Methyldopa—Skin disorder—Methylprednisolone—asthma	3.23e-05	0.000487	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Hydrocortisone—asthma	3.22e-05	0.000486	CcSEcCtD
Methyldopa—Paraesthesia—Hydrocortisone—asthma	3.17e-05	0.000479	CcSEcCtD
Methyldopa—Myalgia—Dexamethasone—asthma	3.15e-05	0.000475	CcSEcCtD
Methyldopa—Myalgia—Betamethasone—asthma	3.15e-05	0.000475	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Hydrocortisone—asthma	3.05e-05	0.00046	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Triamcinolone—asthma	3.03e-05	0.000457	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Methylprednisolone—asthma	3.03e-05	0.000456	CcSEcCtD
Methyldopa—Oedema—Dexamethasone—asthma	3.02e-05	0.000456	CcSEcCtD
Methyldopa—Oedema—Betamethasone—asthma	3.02e-05	0.000456	CcSEcCtD
Methyldopa—Infection—Betamethasone—asthma	3e-05	0.000453	CcSEcCtD
Methyldopa—Infection—Dexamethasone—asthma	3e-05	0.000453	CcSEcCtD
Methyldopa—Paraesthesia—Triamcinolone—asthma	2.99e-05	0.000451	CcSEcCtD
Methyldopa—Paraesthesia—Methylprednisolone—asthma	2.98e-05	0.00045	CcSEcCtD
Methyldopa—Nervous system disorder—Betamethasone—asthma	2.96e-05	0.000447	CcSEcCtD
Methyldopa—Nervous system disorder—Dexamethasone—asthma	2.96e-05	0.000447	CcSEcCtD
Methyldopa—Thrombocytopenia—Dexamethasone—asthma	2.96e-05	0.000446	CcSEcCtD
Methyldopa—Thrombocytopenia—Betamethasone—asthma	2.96e-05	0.000446	CcSEcCtD
Methyldopa—Body temperature increased—Hydrocortisone—asthma	2.79e-05	0.000422	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Dexamethasone—asthma	2.75e-05	0.000415	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Betamethasone—asthma	2.75e-05	0.000415	CcSEcCtD
Methyldopa—Arthralgia—Prednisone—asthma	2.74e-05	0.000414	CcSEcCtD
Methyldopa—Myalgia—Prednisone—asthma	2.74e-05	0.000414	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.72e-05	0.000411	CcSEcCtD
Methyldopa—Paraesthesia—Dexamethasone—asthma	2.71e-05	0.000409	CcSEcCtD
Methyldopa—Paraesthesia—Betamethasone—asthma	2.71e-05	0.000409	CcSEcCtD
Methyldopa—Hypersensitivity—Prednisolone—asthma	2.67e-05	0.000402	CcSEcCtD
Methyldopa—Body temperature increased—Triamcinolone—asthma	2.63e-05	0.000397	CcSEcCtD
Methyldopa—Oedema—Prednisone—asthma	2.63e-05	0.000397	CcSEcCtD
Methyldopa—Infection—Prednisone—asthma	2.61e-05	0.000394	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Dexamethasone—asthma	2.61e-05	0.000393	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Betamethasone—asthma	2.61e-05	0.000393	CcSEcCtD
Methyldopa—Hypersensitivity—Hydrocortisone—asthma	2.6e-05	0.000393	CcSEcCtD
Methyldopa—Nervous system disorder—Prednisone—asthma	2.58e-05	0.000389	CcSEcCtD
Methyldopa—Skin disorder—Prednisone—asthma	2.55e-05	0.000385	CcSEcCtD
Methyldopa—Asthenia—Hydrocortisone—asthma	2.54e-05	0.000383	CcSEcCtD
Methyldopa—Hypersensitivity—Triamcinolone—asthma	2.45e-05	0.00037	CcSEcCtD
Methyldopa—Hypersensitivity—Methylprednisolone—asthma	2.45e-05	0.000369	CcSEcCtD
Methyldopa—Diarrhoea—Hydrocortisone—asthma	2.42e-05	0.000365	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Prednisone—asthma	2.4e-05	0.000361	CcSEcCtD
Methyldopa—Dizziness—Prednisolone—asthma	2.39e-05	0.000361	CcSEcCtD
Methyldopa—Asthenia—Triamcinolone—asthma	2.39e-05	0.00036	CcSEcCtD
Methyldopa—Body temperature increased—Betamethasone—asthma	2.39e-05	0.00036	CcSEcCtD
Methyldopa—Body temperature increased—Dexamethasone—asthma	2.39e-05	0.00036	CcSEcCtD
Methyldopa—Asthenia—Methylprednisolone—asthma	2.38e-05	0.000359	CcSEcCtD
Methyldopa—Paraesthesia—Prednisone—asthma	2.36e-05	0.000356	CcSEcCtD
Methyldopa—Dizziness—Hydrocortisone—asthma	2.34e-05	0.000353	CcSEcCtD
Methyldopa—Rash—Prednisolone—asthma	2.28e-05	0.000344	CcSEcCtD
Methyldopa—Dermatitis—Prednisolone—asthma	2.28e-05	0.000344	CcSEcCtD
Methyldopa—Diarrhoea—Methylprednisolone—asthma	2.27e-05	0.000343	CcSEcCtD
Methyldopa—Headache—Prednisolone—asthma	2.27e-05	0.000342	CcSEcCtD
Methyldopa—Constipation—Prednisone—asthma	2.25e-05	0.000339	CcSEcCtD
Methyldopa—Vomiting—Hydrocortisone—asthma	2.25e-05	0.000339	CcSEcCtD
Methyldopa—Rash—Hydrocortisone—asthma	2.23e-05	0.000336	CcSEcCtD
Methyldopa—Dermatitis—Hydrocortisone—asthma	2.23e-05	0.000336	CcSEcCtD
Methyldopa—Headache—Hydrocortisone—asthma	2.21e-05	0.000334	CcSEcCtD
Methyldopa—Dizziness—Triamcinolone—asthma	2.2e-05	0.000332	CcSEcCtD
Methyldopa—Dizziness—Methylprednisolone—asthma	2.2e-05	0.000331	CcSEcCtD
Methyldopa—Asthenia—Betamethasone—asthma	2.17e-05	0.000327	CcSEcCtD
Methyldopa—Asthenia—Dexamethasone—asthma	2.17e-05	0.000327	CcSEcCtD
Methyldopa—Nausea—Prednisolone—asthma	2.15e-05	0.000324	CcSEcCtD
Methyldopa—Vomiting—Triamcinolone—asthma	2.12e-05	0.000319	CcSEcCtD
Methyldopa—Vomiting—Methylprednisolone—asthma	2.11e-05	0.000319	CcSEcCtD
Methyldopa—Nausea—Hydrocortisone—asthma	2.1e-05	0.000317	CcSEcCtD
Methyldopa—Rash—Triamcinolone—asthma	2.1e-05	0.000317	CcSEcCtD
Methyldopa—Dermatitis—Triamcinolone—asthma	2.1e-05	0.000316	CcSEcCtD
Methyldopa—Rash—Methylprednisolone—asthma	2.09e-05	0.000316	CcSEcCtD
Methyldopa—Dermatitis—Methylprednisolone—asthma	2.09e-05	0.000316	CcSEcCtD
Methyldopa—Headache—Triamcinolone—asthma	2.09e-05	0.000315	CcSEcCtD
Methyldopa—Headache—Methylprednisolone—asthma	2.08e-05	0.000314	CcSEcCtD
Methyldopa—Body temperature increased—Prednisone—asthma	2.08e-05	0.000314	CcSEcCtD
Methyldopa—Diarrhoea—Dexamethasone—asthma	2.07e-05	0.000312	CcSEcCtD
Methyldopa—Diarrhoea—Betamethasone—asthma	2.07e-05	0.000312	CcSEcCtD
Methyldopa—Dizziness—Dexamethasone—asthma	2e-05	0.000301	CcSEcCtD
Methyldopa—Dizziness—Betamethasone—asthma	2e-05	0.000301	CcSEcCtD
Methyldopa—Nausea—Triamcinolone—asthma	1.98e-05	0.000298	CcSEcCtD
Methyldopa—Nausea—Methylprednisolone—asthma	1.97e-05	0.000298	CcSEcCtD
Methyldopa—Hypersensitivity—Prednisone—asthma	1.94e-05	0.000292	CcSEcCtD
Methyldopa—Vomiting—Betamethasone—asthma	1.92e-05	0.00029	CcSEcCtD
Methyldopa—Vomiting—Dexamethasone—asthma	1.92e-05	0.00029	CcSEcCtD
Methyldopa—Rash—Betamethasone—asthma	1.9e-05	0.000287	CcSEcCtD
Methyldopa—Rash—Dexamethasone—asthma	1.9e-05	0.000287	CcSEcCtD
Methyldopa—Dermatitis—Dexamethasone—asthma	1.9e-05	0.000287	CcSEcCtD
Methyldopa—Dermatitis—Betamethasone—asthma	1.9e-05	0.000287	CcSEcCtD
Methyldopa—Headache—Betamethasone—asthma	1.89e-05	0.000285	CcSEcCtD
Methyldopa—Headache—Dexamethasone—asthma	1.89e-05	0.000285	CcSEcCtD
Methyldopa—Asthenia—Prednisone—asthma	1.89e-05	0.000285	CcSEcCtD
Methyldopa—Diarrhoea—Prednisone—asthma	1.8e-05	0.000271	CcSEcCtD
Methyldopa—Nausea—Dexamethasone—asthma	1.79e-05	0.000271	CcSEcCtD
Methyldopa—Nausea—Betamethasone—asthma	1.79e-05	0.000271	CcSEcCtD
Methyldopa—Dizziness—Prednisone—asthma	1.74e-05	0.000262	CcSEcCtD
Methyldopa—Vomiting—Prednisone—asthma	1.67e-05	0.000252	CcSEcCtD
Methyldopa—Rash—Prednisone—asthma	1.66e-05	0.00025	CcSEcCtD
Methyldopa—Dermatitis—Prednisone—asthma	1.66e-05	0.00025	CcSEcCtD
Methyldopa—Headache—Prednisone—asthma	1.65e-05	0.000249	CcSEcCtD
Methyldopa—Nausea—Prednisone—asthma	1.56e-05	0.000236	CcSEcCtD
Methyldopa—COMT—Metabolism—NQO1—asthma	1.47e-05	0.000536	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	1.47e-05	0.000535	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CYSLTR1—asthma	1.47e-05	0.000533	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—POMC—asthma	1.44e-05	0.000526	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CXCL10—asthma	1.44e-05	0.000525	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ADCY2—asthma	1.44e-05	0.000524	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—asthma	1.44e-05	0.000522	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS1—asthma	1.42e-05	0.000518	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDE4A—asthma	1.42e-05	0.000517	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—C5AR1—asthma	1.42e-05	0.000515	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—VIP—asthma	1.42e-05	0.000515	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—UTS2—asthma	1.42e-05	0.000515	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL3—asthma	1.41e-05	0.000512	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRB2—asthma	1.4e-05	0.00051	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—asthma	1.39e-05	0.000504	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTP1—asthma	1.38e-05	0.000503	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—ALB—asthma	1.38e-05	0.000503	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HMOX1—asthma	1.36e-05	0.000496	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ITPR1—asthma	1.36e-05	0.000495	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCR4—asthma	1.36e-05	0.000494	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CAT—asthma	1.35e-05	0.00049	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—RHOA—asthma	1.34e-05	0.000486	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CYSLTR1—asthma	1.33e-05	0.000484	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—KNG1—asthma	1.33e-05	0.000483	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ARG1—asthma	1.32e-05	0.000482	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL2RB—asthma	1.31e-05	0.000475	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PDE4D—asthma	1.29e-05	0.000471	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—C5AR1—asthma	1.29e-05	0.000468	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL11—asthma	1.29e-05	0.000468	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—VIP—asthma	1.29e-05	0.000468	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—UTS2—asthma	1.29e-05	0.000468	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PLA2G4A—asthma	1.27e-05	0.000463	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTM1—asthma	1.27e-05	0.000463	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FCER2—asthma	1.27e-05	0.000461	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—C3AR1—asthma	1.27e-05	0.000461	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ALB—asthma	1.26e-05	0.000459	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—C5—asthma	1.26e-05	0.000459	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PDE4B—asthma	1.26e-05	0.000459	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TACR1—asthma	1.26e-05	0.000459	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—EDN1—asthma	1.25e-05	0.000455	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL5—asthma	1.24e-05	0.000452	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCR4—asthma	1.23e-05	0.000448	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTP1—asthma	1.23e-05	0.000447	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CYSLTR2—asthma	1.22e-05	0.000444	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HMOX1—asthma	1.21e-05	0.000441	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ITPR1—asthma	1.21e-05	0.00044	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALDH7A1—asthma	1.2e-05	0.000436	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CAT—asthma	1.19e-05	0.000435	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL2RB—asthma	1.19e-05	0.000432	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ITPR1—asthma	1.18e-05	0.000431	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LTB4R—asthma	1.18e-05	0.000429	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTGDR—asthma	1.18e-05	0.000429	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL22—asthma	1.18e-05	0.000429	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDE4D—asthma	1.18e-05	0.000428	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPP2CA—asthma	1.17e-05	0.000426	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCR3—asthma	1.15e-05	0.00042	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ARG2—asthma	1.15e-05	0.000418	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	1.15e-05	0.000418	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—C5—asthma	1.15e-05	0.000417	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TACR1—asthma	1.15e-05	0.000417	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDE4B—asthma	1.15e-05	0.000417	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PLA2G4A—asthma	1.13e-05	0.000411	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTM1—asthma	1.13e-05	0.000411	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPY—asthma	1.12e-05	0.000409	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	1.12e-05	0.000409	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IL2—asthma	1.12e-05	0.000408	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCR5—asthma	1.12e-05	0.000407	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CXCL8—asthma	1.12e-05	0.000407	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLA2G4A—asthma	1.11e-05	0.000403	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CSF2—asthma	1.09e-05	0.000398	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—C3—asthma	1.09e-05	0.000398	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AGTR2—asthma	1.08e-05	0.000395	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCR3—asthma	1.05e-05	0.000381	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPP2CA—asthma	1.04e-05	0.000378	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—EDNRB—asthma	1.04e-05	0.000378	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TAC1—asthma	1.03e-05	0.000374	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPS—asthma	1.03e-05	0.000374	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPY—asthma	1.02e-05	0.000372	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PPP2CA—asthma	1.02e-05	0.000371	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CXCR3—asthma	1.01e-05	0.000367	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTGDR2—asthma	1e-05	0.000365	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPSR1—asthma	1e-05	0.000365	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PMCH—asthma	1e-05	0.000365	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HRH4—asthma	1e-05	0.000365	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL2RA—asthma	9.86e-06	0.000359	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AGTR2—asthma	9.85e-06	0.000359	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CSF2RB—asthma	9.8e-06	0.000357	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TACR2—asthma	9.6e-06	0.00035	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCR8—asthma	9.6e-06	0.00035	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL5—asthma	9.56e-06	0.000348	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—asthma	9.53e-06	0.000347	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALOX5AP—asthma	9.52e-06	0.000346	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALOX15—asthma	9.52e-06	0.000346	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PDGFB—asthma	9.51e-06	0.000346	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—EDNRB—asthma	9.43e-06	0.000343	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL17—asthma	9.42e-06	0.000343	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TAC1—asthma	9.34e-06	0.00034	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPS—asthma	9.34e-06	0.00034	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CDK2—asthma	9.23e-06	0.000336	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLAU—asthma	9.23e-06	0.000336	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—BDKRB2—asthma	9.22e-06	0.000336	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CXCR3—asthma	9.16e-06	0.000333	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CHAT—asthma	9.08e-06	0.00033	CbGpPWpGaD
Methyldopa—DDC—Metabolism—POMC—asthma	8.98e-06	0.000327	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADCY2—asthma	8.92e-06	0.000325	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL3—asthma	8.89e-06	0.000324	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	8.88e-06	0.000323	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—asthma	8.75e-06	0.000318	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—POMC—asthma	8.74e-06	0.000318	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL5—asthma	8.68e-06	0.000316	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—FN1—asthma	8.58e-06	0.000312	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL2—asthma	8.55e-06	0.000311	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS2—asthma	8.48e-06	0.000309	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDE4A—asthma	8.39e-06	0.000306	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—KIF3A—asthma	8.39e-06	0.000306	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—KNG1—asthma	8.39e-06	0.000305	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—BDKRB2—asthma	8.37e-06	0.000305	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AGTR1—asthma	8.34e-06	0.000304	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ALB—asthma	8.19e-06	0.000298	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CXCL10—asthma	8.15e-06	0.000297	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADCY2—asthma	8.1e-06	0.000295	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALOX5—asthma	8.09e-06	0.000295	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL3—asthma	8.08e-06	0.000294	CbGpPWpGaD
Methyldopa—COMT—Metabolism—POMC—asthma	7.97e-06	0.00029	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRB2—asthma	7.91e-06	0.000288	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CYSLTR1—asthma	7.86e-06	0.000286	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NOS3—asthma	7.83e-06	0.000285	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CARM1—asthma	7.72e-06	0.000281	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—KNG1—asthma	7.62e-06	0.000277	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DCN—asthma	7.61e-06	0.000277	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL11—asthma	7.59e-06	0.000276	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CMA1—asthma	7.59e-06	0.000276	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—C5AR1—asthma	7.59e-06	0.000276	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VIP—asthma	7.59e-06	0.000276	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—UTS2—asthma	7.59e-06	0.000276	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AGTR1—asthma	7.57e-06	0.000276	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ITPR1—asthma	7.48e-06	0.000272	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CXCL10—asthma	7.4e-06	0.000269	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALDH2—asthma	7.4e-06	0.000269	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCR4—asthma	7.28e-06	0.000265	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALB—asthma	7.27e-06	0.000265	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRB2—asthma	7.19e-06	0.000262	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS2—asthma	7.16e-06	0.000261	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SERPINE1—asthma	7.14e-06	0.00026	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—STAT6—asthma	7.14e-06	0.00026	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ALB—asthma	7.13e-06	0.000259	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—EDN1—asthma	7.07e-06	0.000257	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTT1—asthma	7.04e-06	0.000256	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCL5—asthma	7.02e-06	0.000255	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL2RB—asthma	7.01e-06	0.000255	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NOS3—asthma	6.95e-06	0.000253	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDE4D—asthma	6.94e-06	0.000253	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CSF2—asthma	6.91e-06	0.000252	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—RHOA—asthma	6.89e-06	0.000251	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS3—asthma	6.82e-06	0.000248	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ITPR1—asthma	6.8e-06	0.000247	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDE4B—asthma	6.77e-06	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—C5—asthma	6.77e-06	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TACR1—asthma	6.77e-06	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CXCL8—asthma	6.76e-06	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—EDN1—asthma	6.42e-06	0.000234	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL5—asthma	6.37e-06	0.000232	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS2—asthma	6.36e-06	0.000232	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PLA2G4A—asthma	6.35e-06	0.000231	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCR5—asthma	6.32e-06	0.00023	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CSF2—asthma	6.28e-06	0.000228	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTEN—asthma	6.25e-06	0.000227	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL2RA—asthma	6.23e-06	0.000227	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCR3—asthma	6.19e-06	0.000225	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—C3—asthma	6.18e-06	0.000225	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPY—asthma	6.03e-06	0.00022	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NQO1—asthma	5.85e-06	0.000213	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PPP2CA—asthma	5.85e-06	0.000213	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AGTR2—asthma	5.82e-06	0.000212	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL2—asthma	5.78e-06	0.00021	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCR5—asthma	5.74e-06	0.000209	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADCY2—asthma	5.73e-06	0.000208	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL2RA—asthma	5.66e-06	0.000206	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—C3—asthma	5.61e-06	0.000204	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EDNRB—asthma	5.57e-06	0.000203	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTEN—asthma	5.55e-06	0.000202	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPS—asthma	5.52e-06	0.000201	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TAC1—asthma	5.52e-06	0.000201	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CXCR3—asthma	5.41e-06	0.000197	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CYBA—asthma	5.24e-06	0.000191	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PARP1—asthma	5.13e-06	0.000187	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL5—asthma	5.13e-06	0.000187	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—BDKRB2—asthma	4.95e-06	0.00018	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—POMC—asthma	4.94e-06	0.00018	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VEGFA—asthma	4.91e-06	0.000179	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTP1—asthma	4.88e-06	0.000178	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HMOX1—asthma	4.81e-06	0.000175	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ITPR1—asthma	4.8e-06	0.000175	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADCY2—asthma	4.79e-06	0.000174	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL3—asthma	4.77e-06	0.000174	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CAT—asthma	4.75e-06	0.000173	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TGFB1—asthma	4.51e-06	0.000164	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—KNG1—asthma	4.5e-06	0.000164	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—POMC—asthma	4.49e-06	0.000163	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLA2G4A—asthma	4.48e-06	0.000163	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTM1—asthma	4.48e-06	0.000163	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AGTR1—asthma	4.47e-06	0.000163	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL2—asthma	4.39e-06	0.00016	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6R—asthma	4.38e-06	0.000159	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CXCL10—asthma	4.37e-06	0.000159	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—RHOA—asthma	4.35e-06	0.000158	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTRK1—asthma	4.29e-06	0.000156	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRB2—asthma	4.24e-06	0.000155	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPP2CA—asthma	4.13e-06	0.00015	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ITPR1—asthma	4.01e-06	0.000146	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—RHOA—asthma	3.95e-06	0.000144	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CD86—asthma	3.82e-06	0.000139	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CXCL8—asthma	3.82e-06	0.000139	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EDN1—asthma	3.79e-06	0.000138	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL5—asthma	3.76e-06	0.000137	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PLA2G4A—asthma	3.75e-06	0.000136	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CSF2—asthma	3.71e-06	0.000135	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL2—asthma	3.65e-06	0.000133	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SMAD3—asthma	3.61e-06	0.000131	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CXCL8—asthma	3.47e-06	0.000126	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PPP2CA—asthma	3.45e-06	0.000126	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCR5—asthma	3.39e-06	0.000123	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL2RA—asthma	3.34e-06	0.000122	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL2—asthma	3.32e-06	0.000121	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—C3—asthma	3.31e-06	0.000121	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDGFB—asthma	3.23e-06	0.000117	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—POMC—asthma	3.17e-06	0.000115	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LEP—asthma	3.08e-06	0.000112	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FN1—asthma	2.91e-06	0.000106	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALB—asthma	2.89e-06	0.000105	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NOS3—asthma	2.76e-06	0.000101	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—POMC—asthma	2.65e-06	9.65e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL2—asthma	2.59e-06	9.44e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6R—asthma	2.59e-06	9.41e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—EGFR—asthma	2.54e-06	9.23e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS2—asthma	2.53e-06	9.2e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SERPINE1—asthma	2.42e-06	8.81e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RHOA—asthma	2.34e-06	8.5e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOS3—asthma	2.31e-06	8.41e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTEN—asthma	2.2e-06	8.02e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CXCL8—asthma	2.05e-06	7.46e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL2—asthma	1.96e-06	7.13e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—asthma	1.95e-06	7.1e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MMP9—asthma	1.85e-06	6.75e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTEN—asthma	1.84e-06	6.71e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VEGFA—asthma	1.67e-06	6.06e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—STAT3—asthma	1.65e-06	6e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TGFB1—asthma	1.53e-06	5.56e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EGFR—asthma	1.5e-06	5.45e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—asthma	1.15e-06	4.19e-05	CbGpPWpGaD
